Impact of an Infectious Disease Specialist on an Antimicrobial Stewardship Program at a Resource-Limited, Non-Academic Community Hospital in Korea

被引:4
作者
Kim, Yong Chan [1 ,2 ]
Kim, Eun Jin [1 ]
Heo, Jung Yeon [1 ]
Choi, Young Hwa [1 ]
Ahn, Jin Young [3 ]
Jeong, Su Jin [3 ]
Ku, Nam Su [3 ]
Choi, Jun Yong [3 ]
Yeom, Joon-sup [3 ]
Kim, Ha Yan [4 ]
机构
[1] Ajou Univ, Dept Infect Dis, Sch Med, Suwon 16499, South Korea
[2] Yonsei Univ, Dept Med, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea
[4] Yonsei Univ, Biostat Collaborat Unit, Coll Med, Seoul 03722, South Korea
关键词
anti-bacterial agents; antimicrobial stewardship program; infectious disease specialist; antimicrobial resistance; community hospital; Korea; ANTIBIOTIC STEWARDSHIP; RESTRICTION; CONSUMPTION; CARBAPENEM; RESISTANCE; EMERGENCE; POLICY;
D O I
10.3390/jcm8091293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Implementing a successful antimicrobial stewardship program (ASP) is difficult for non-academic community (NAC) hospitals due to insufficient infrastructure. Aim: We evaluated the impact of an infectious disease specialist (IDS) on implementing an ASP in a resource-limited setting in Korea. Methods: A retrospective study was performed at a NAC hospital between June 2015 and August 2018. An IDS has led an ASP at the hospital since June 2017. We used an interrupted time series analysis to evaluate longitudinal effects of the IDS-led ASP on the amount of antibiotic use and incidence of multidrug-resistant organism (MDRO) acquisition. Findings: Total antibiotic use changed from 698.82 +/- 74.41 to 602.09 +/- 69.94 defined daily dose/1000 patient-days (PDs) after intervention. An immediate reduction in the use of carbapenems, glycopeptides, penicillins, and other antibiotics followed the IDS-led ASP. The 3rd/4th generation cephalosporins and carbapenems prescription rates decreased in slope after the intervention. Incidence of MDRO acquisition changed from 1.38, 0.78, and 0.21/1000 PDs to 1.06, 0.15, and 0.32/1000 PDs in methicillin-resistant Staphylococcus aureus, multidrug-resistant Acinetobacter baumannii, and multidrug-resistant Pseudomonas aeruginosa, respectively. The incidence of methicillin-resistant Staphylococcus aureus and multidrug-resistant Acinetobacter baumannii acquisition immediately decreased following intervention. Conclusion: An IDS can implement a successful ASP by reducing antibiotic consumption and MDRO acquisition at resource-limited NAC hospitals.
引用
收藏
页数:12
相关论文
共 31 条
  • [1] Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
    Baggs, James
    Fridkin, Scott K.
    Pollack, Lori A.
    Srinivasan, Arjun
    Jernigan, John A.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (11) : 1639 - 1648
  • [2] Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118
  • [3] Implementation and first-year results of an antimicrobial stewardship program at a community hospital
    Bartlett, James M.
    Siola, Patricia L.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (11) : 943 - 949
  • [4] Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
    Baur, David
    Gladstone, Beryl Primrose
    Burkert, Francesco
    Carrara, Elena
    Foschi, Federico
    Doebele, Stefanie
    Tacconelli, Evelina
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (09) : 990 - 1001
  • [5] Clinical and Laboratory Standards Institute, PERFORMANCE STANDARD
  • [6] Surveillance of Overall Hospital Antibiotic Consumption: Is Stratification according to Hospital Size the Best Method?
    Couderc, C.
    Lacave, L.
    L'Heriteau, F.
    Astagneau, P.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (12) : 1223 - 1225
  • [7] Day SR, 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv164, 10.1093/ofid/ofv064]
  • [8] An antibiotic policy to prevent emergence of resistant bacilli
    de Man, P
    Verhoeven, BAN
    Verbrugh, HA
    Vos, MC
    van den Anker, JN
    [J]. LANCET, 2000, 355 (9208) : 973 - 978
  • [9] The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
    Gilbert, David N.
    Guidos, Robert J.
    Boucher, Helen W.
    Talbot, George H.
    Spellberg, Brad
    Edwards, John E., Jr.
    Scheld, W. Michael
    Bradley, John S.
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1081 - 1083
  • [10] Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
    Golkar, Zhabiz
    Bagasra, Omar
    Pace, Donald Gene
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (02): : 129 - 136